Navigating Difficult Conversations in Cancer Pain Management
Difficult conversations in cancer pain management should include core values and principles, setting realistic expectations, and building the patient-client relationship from the very beginning.
Tackling the Adverse Events of Immunotherapy
August 17th 2022Most patients who receive immunotherapies will experience few, if any, treatment-related adverse effects (AEs). But some patients receiving these treatments can experience serious AEs caused by an overactivation of the immune system and its effects on healthy cells.
Experts Make the Case for Buprenorphine Use in Cancer-Related Pain Management
June 28th 2022Mary Lynn McPherson, PharmD, BCPS, FAAHPM, and Amy A. Case, MD, FAAHPM, argue that buprenorphine should play a larger role in cancer-related pain management because of its unique pharmacology and consequent safety profile.
Nurse Takeaways: How to Improve a Patient’s Experience With Sotorasib and Optimize NSCLC Treatment
May 26th 2022Oncology nurses present their experiences treating patients with sotorasib in the phase 1/2 CodeBreaK 100 trial and optimal symptom management strategies to improve patient outcomes with the drug.
2-Year Follow-Up Showcases Sotorasib Benefit in KRAS G12C+ NSCLC
April 15th 2022Longer follow-up data from the phase 1/2 CodeBreaK 100 trial show that patients with KRAS G12C–mutant non–small cell lung cancer experienced improved prolonged overall survival and encouraging response rates with sotorasib.
Roswell Park Nurse Residency Program Nationally Recognized and Accredited
September 30th 2021With education one of the cornerstones of its mission, Roswell Park Comprehensive Cancer Center is pleased to announce that its Nurse Residency Program has achieved Accreditation with Distinction from the American Nurses Credentialing Center (ANCC).